. 2024 Mar 18;75:103714. doi: 10.1016/j.breast.2024.103714

Table 1.

Number of included studies by country and time to diagnosis and/or treatment.

Region	Country	World Bank Classification	No of Studies Conducted				Total No of Studies Conducted
			Time to Diagnosis		Time to Treatment	Both Time to Diagnosis & Treatment
			Pre-contact Interval	Post-contact Interval	Time to Treatment	Both Time to Diagnosis & Treatment
Sub Saharan Africa			5		2	2	5
1	Mali [20]	LIC	1	1	1	1	1
2	Zambia [19,30]	LIC	2^a	2^a	0	0	2^a
3	Uganda [19,30]	LIC	2^a	2^a	0	0	2^a
4	Nigeria [19,30]	LMIC	2^a	2^a	0	0	2^a
5	Namibia [19,30]	HMIC	2^a	2^a	0	0	2^a
6	Rwanda [29]	LIC	1	1	0	0	1
7	Kenya [34]	LMIC	1	1	1	1	1
Middle East and North Africa			1		1	1	1
8	Syria [35]	LIC	1	1	1	1	1
East Asia and Pacific			2		2	1	3
9	Malaysia [25,28]	HMIC	1	1	2	1	2
10	Thailand [15]	HMIC	1	1	0	0	1
South Asia			3		3	3	3
11	Pakistan [24]	LMIC	1	1	1	1	1
12	Sri Lanka [21,22]	LMIC	2^b	2^b	2^b	2^b	2^b
Latin America and Caribbean			3		7	1	9
13	Brazil [[16], [17], [18],26,27,32,33]	HMIC	0	2	6	1	7
14	Mexico [23,31]	HMIC	1	1	1	0	2
Total			14		15	8	21

LIC: low-income countries; LMIC: Low middle-income countries; HMIC: High middle-income countries.

Multicentric and two studies conducted with same participants (Both studies were counted but the time interval was counted/included only once).

Two studies conducted with the same participants.